BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 7872315)

  • 1. Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis.
    De'Oliviera J; Gaskin G; Dash A; Rees AJ; Pusey CD
    Am J Kidney Dis; 1995 Mar; 25(3):380-9. PubMed ID: 7872315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis.
    Kyndt X; Reumaux D; Bridoux F; Tribout B; Bataille P; Hachulla E; Hatron PY; Duthilleul P; Vanhille P
    Am J Med; 1999 May; 106(5):527-33. PubMed ID: 10335724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antineutrophil cytoplasmic antibodies].
    Sebastiani GD
    Reumatismo; 2009; 61(1):69-76. PubMed ID: 19370191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis.
    Fienberg R; Mark EJ; Goodman M; McCluskey RT; Niles JL
    Hum Pathol; 1993 Feb; 24(2):160-8. PubMed ID: 8381764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
    Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
    Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antineutrophil cytoplasmic autoantibodies in systemic vasculitis].
    Hagemo JS; Aasarød K; Moen T
    Tidsskr Nor Laegeforen; 2002 May; 122(12):1185-8. PubMed ID: 12089844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineutrophil cytoplasmic antibodies.
    Bosch X; Guilabert A; Font J
    Lancet; 2006 Jul; 368(9533):404-18. PubMed ID: 16876669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophil cytoplasmic autoantibody--associated glomerulonephritis: potentially reversible disease.
    Wen SF
    J Formos Med Assoc; 1994 Jul; 93(7):545-61. PubMed ID: 7866052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between anti-neutrophil cytoplasmic antibody determined with conventional binding and the capture assay, and long-term clinical course in vasculitis.
    Gisslén K; Wieslander J; Westberg G; Herlitz H
    J Intern Med; 2002 Feb; 251(2):129-35. PubMed ID: 11905588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis.
    Tervaert JW; Limburg PC; Elema JD; Huitema MG; Horst G; The TH; Kallenberg CG
    Am J Med; 1991 Jul; 91(1):59-66. PubMed ID: 1677531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).
    Talor MV; Stone JH; Stebbing J; Barin J; Rose NR; Burek CL
    Clin Exp Immunol; 2007 Oct; 150(1):42-8. PubMed ID: 17614969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.
    Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN
    Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANCA-associated vasculitis.
    Damoiseaux JG; Slot MC; Vaessen M; Stegeman CA; Van Paassen P; Tervaert JW
    J Clin Immunol; 2005 May; 25(3):202-8. PubMed ID: 15981084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ANCA-associated forms of vasculitis].
    Helmchen U; Kneissler U; Prall F
    Verh Dtsch Ges Pathol; 1996; 80():38-45. PubMed ID: 9065053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis.
    Gaskin G; Savage CO; Ryan JJ; Jones S; Rees AJ; Lockwood CM; Pusey CD
    Nephrol Dial Transplant; 1991; 6(10):689-94. PubMed ID: 1754104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Wegener's granulomatosis and microscopic polyangiitis].
    Pagnoux C
    Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis and other diseases: clinical issues.
    Galperin C; Hoffman GS
    Cleve Clin J Med; 1994; 61(6):416-27. PubMed ID: 7828332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of anti-neutrophil cytoplasmic antibodies, anti-proteinase 3 and anti-myeloperoxidase in management of small vessel vasculitis].
    Ara J; Mirapeix E; Rodríguez R; Pascual J; Alvarez L; Darnell A
    Med Clin (Barc); 1998 Oct; 111(14):536-8. PubMed ID: 9859079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
    Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M
    J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.